The Radiation Therapy Oncology Group (RTOG) and US Oncology have entered into a partnership to increase patient access to national cancer trials with a radiation focus, Philadelphia-based RTOG said.
The collaboration will allow patients receiving cancer care at practices affiliated with Houston-based US Oncology to have access to RTOG trials for disease sites including brain, head and neck, lung, gastrointestinal, genitourinary, cervix, and breast cancers. RTOG trials focus on testing the integration of radiation therapy with new systemic therapies and surgery.
The partnership began with 10 US Oncology-affiliated practices working as a network; due to interest from radiation oncologists, the number expanded to 14 sites. The first US Oncology patient was enrolled in an RTOG trial in March of this year. From March to mid-October, a total of 17 patients from eight fully credentialed sites have been enrolled, RTOG said.
Related Reading
Combo cancer therapy costly up front, but saves money in long run, November 13, 2006
RTOG launches temozolomide study, March 17, 2006
Copyright © 2008 AuntMinnie.com
